Navigation Links
Nventa completes enrollment and initial dosing of second cohort in Phase 1 HspE7 safety trial
Date:12/6/2007

SAN DIEGO, CA, Dec. 6 /PRNewswire-FirstCall/ - Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced that the Company has completed enrollment and initiated dosing of the second cohort of patients in its Phase 1 dose escalation trial examining the safety of its lead candidate, HspE7, in patients with cervical dysplasia, a precursor to cervical cancer. HspE7 is an investigational therapeutic vaccine targeting human papillomavirus (HPV)-related diseases. Patients in this cohort have received the first of three immunizations of 500 mcg of HspE7 with 500 mcg of adjuvant.

In addition to safety and tolerability assessment, Nventa will also collect immunological data from these patients at the end of each cohort that may provide an early indication of potential efficacy of the compound. All patients will be typed for class I and II human leukocyte antigen (HLA) subtypes, and will be evaluated for cytokine responses, anti-HspE7 antibodies and cellular (T-cell) immunology.

"We are very pleased that patient enrollment in this study has accelerated," said Peter Emtage, Ph.D., Vice President of Research and Development at Nventa. "We believe this is in recognition of the enthusiasm and support from participating clinical trial sites. With the majority of all study participants in the queue, we expect continued progress with enrollment in this Phase 1 study."

Affiliations and investigators in this trial currently include the Montefiore Medical Center; William D. Kolton, M.D. of San Diego, California; Linda Roman, M.D. of the University of Southern California (USC); Michael L. Twede, M.D. of the Salt Lake Women's Center in Sandy, Utah; and Mark T. Saunders, M.D. at the Mt. Timpanogos Women's Healthcare/Physician's Research in Pleasant Grove, Utah.

The trial is expected to dose up to 5 cohorts totaling twenty-four patients. Four cohorts will be administered 500 mcg of HspE7 and doses of 50, 500, 1,000, or 2,000 mcg of adjuvant containi
'/>"/>

SOURCE Nventa Biopharmaceuticals Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Nventa Initiates HspE7 Phase 1 Cervical Dysplasia Trial
2. Nventa announces publication of HspE7 data
3. Nventas CEO to present at two upcoming investor conferences
4. Nventa updates progress of cervical dysplasia trial with new HspE7
5. Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results
6. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
7. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. Carrington Completes $8 Million Financing
10. Proteon Therapeutics Completes $12 Million Financing and Hires CFO
11. New Brunswick Scientific Completes Merger Transaction with Eppendorf
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...FirstCall/ -- Eli Lilly and,Company (NYSE: LLY ) ...ion,of SGX Pharmaceuticals, Inc. (Nasdaq: SGXP ),...n drug discovery and development in the area,of on...s Special,Stockholders Meeting, in which a majorit... agreement with Lilly. Under the agreement, Lilly ...
(Date:8/20/2008)... and Caregivers, Grassroots ...ewswire-USNewswire/ -- Inc. Magazine has,named Sen...an for,low-income seniors, the number one fastest-...rt of Inc.,s annual list of the country,s 500 fast...1,000 percent from 2004 to 2007., "This is a rewa...
(Date:8/20/2008)...ll/ -- CEL-SCI CORPORATION,(Amex: CVM ) reports f...ing,June 30, 2008., The Company,s loss from opera...76,679 versus a loss of $3,776,263 during the same...ns for the nine months ended June 30, 2008,was $7,...e nine months in,2007., The net loss per common s...
(Date:8/20/2008).../ -- Huifeng Bio-Pharmaceutical,Technology, Inc (O...producer of plant extracts and pharmaceutical raw ... and food production, today announced it will,be i... August 19-21 in Rio,de Janeiro, Brazil., "Unpara...volved in the,pharmaceutical raw materials industr...
Breaking Biology Technology:Lilly Announces Completion of SGX Acquisition 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 3CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 2CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 3CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 4CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 5Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil 2
...e announced on Monday that for the second year in...e application in the KLAS rankings of health inf...-year rankings API received the highest possible d...en 15 and 20 percent higher than its competitors i...nstrating an overall 3 percent increase from last ...
...umn, I raised the premise that in the early years ...roviding radically new solutions to health care. ,...k n roll where it was also not about making money ...(without getting jailed for it). Today, both busin...ustries that have become mainstream. , ,While the...
...t Chicago, with the assistance of GE Healthcare ...agnetic resonance imaging scanner, officials annou...nternal anatomy and brain functions in a non-invas...is a unit of magnetic strength. The magnet used in...he strength of the Earths magnetic field. , ,While...
... science is revolutionizing technology, and the Un...han $13 million to harness its potential during th...nology, is the study of materials and processes at...e under the lens of almost any microscope. These m...ith a single unit equal to one billionth of a mete...
Other Biology Technology:API Software best in health-care customer satisfaction, says KLAS report 2Biotech IPOs bring in encouraging sums 2Biotech IPOs bring in encouraging sums 3UW-Madison gets $13 million to study nanotech 2
(Date:8/20/2008)...ily of biodegradable polymers called polyketals an... inflammatory illnesses as acute lung injury, acut...delivering drugs, proteins and snips of ribonuclei...polyketal microparticles we developed are simply a...iseased area as quickly as possible," said Niren M...
(Date:8/20/2008)...LUMBUS, Ohio -- Researchers here have found a way ...n very efficiently. , A new catalyst makes hydro...ble temperature, and using inexpensive ingredients...ecular engineering at Ohio State University, said ...others being developed around the world, because i...
(Date:8/19/2008)..., Aug. 19, 2008 We all understand that even the t...pportunities and challenges for plants, animals an...ng on a microscopic level and what those changes c...rth or how mankind,s day-to-day experiences could...rchers Yuriy Fofanov and Lennart Johnsson understa...
(Date:8/19/2008)..., WI, August 18, 2008 -- Like most things that exi...asily forgotten, but while flowers, leaves, and ot...nt roots are equally deserving of our appreciation...zling ornamental lies a root system that makes it ... plants, extract water and nutrients from soil, an...
Breaking Biology News(10 mins):Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 3A better way to make hydrogen from biofuels 2A better way to make hydrogen from biofuels 3UH researchers win top prize for research with humanitarian applications 2UH researchers win top prize for research with humanitarian applications 3Getting to the root of the matter 2American Idol Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children wit 3497 1American Idol Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children wit 3497 2American Idol Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children wit 3497 3American Idol Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children wit 3497 4American Idol Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children wit 3497 5Survey Sees Mass CEOs as Bullish on Own Businesses 1218 1Survey Sees Mass CEOs as Bullish on Own Businesses 1218 2New membrane strips carbon dioxide from natural gas faster and better 766 1New membrane strips carbon dioxide from natural gas faster and better 766 2New membrane strips carbon dioxide from natural gas faster and better 766 3AIDS Drugs May Protect Brain 3493 1AIDS Drugs May Protect Brain 3493 2
...earchers have found that the cause of chronic sinu...- not in the nasal and sinus tissue targeted by st...n the August issue of Journal of Allergy and Clini... strikingly teaches against what has been thought ...ion: that inflammatory cells break down, releasing...
...r manipulating macromolecules has been developed b...ana-Champaign. The technique uses double-stranded ...In previous DNA nanotechnology efforts, duplex DNA...ometrical objects in three dimensions. Instead of ...rchers are using DNA to control the folding and re...
...r manipulating macromolecules has been developed b...ana-Champaign. The technique uses double-stranded ...In previous DNA nanotechnology efforts, duplex DNA...ometrical objects in three dimensions. Instead of ...rchers are using DNA to control the folding and re...
...ldren could be saved if $5.1 billion in new resour...ere provided each year, according to researchers f...ealth and other institutions. Approximately 90 per...und the world. In those countries, the average cos...a. With the recent publication of the potential im...
Other Biology News:Chronic Sinus Infection Thought To Be Tissue Issue, Mayo Clinic Scientists Show It's Snot 2UN successfully tests 'green' pesticide against locusts 2DNA constraints control structure of attached macromolecules 2$5.1 billion would save 6 million children 2$5.1 billion would save 6 million children 3
...for Optimal Microdissection , CapSure HS and CapS...traction of populations of pure cells from tissue ...icrodissection., Ensure the Integrity of Microdi... All CapSure LCM Caps have a patented transfer fil...
Opticon continuous fluorescence detector; includes optical base, analysis software, computer and monitor (this is an accessory for the DNA Engine thermal cyclers which must be ordered seperately)
... systems are highly sensitive laser confocal syste...e are advanced scanners that meet your expectation...kground level, and optimizing the signal on the bo...ased sensitivity. Results with VersArray ChipReade...
Bio-Plex Manager software, version 3.0, 5 license netshare, is a five-user software package that provides access to data from the Bio-Plex suspension array system from a server. This version does not
Biology Products: